Using NICU Discharge Education Tools to Enhance Discharge Preparation for Parents of Moderate to Late Preterm Infants
Launched by NORTHWELL HEALTH · Dec 11, 2023
Trial Information
Current as of July 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Currently, parents of 33-36 weeks gestational age neonates discharged from the NICU receive discharge-related information, including feeding plan, medications, follow up appointments, and more, from their discharge summary completed in the electronic medical record. This moderate to late preterm population is a unique transitory preterm population in the NICU because while these infants do not face the same risk of medical complications as their younger counterparts, they do require more focused management for very specific risks of prematurity, including poor oromotor skills, glycemic cont...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent and/or legal guardian of all preterm infants born at a gestational age (GA) between 33 weeks and 0 days, and 36 weeks and 6 days, at Cohen Children's Medical Center (CCMC) that will be admitted to and discharged from the NICU will be included in this study.
- • A maximum of one parent/guardian for each eligible infant will be included in the study.
- • Twin infants will be treated as separate study subjects.
- • The nurse in charge of discharging the eligible infant will be included in the study.
- Exclusion Criteria:
- • Parents of infants not being discharged to home from CCMC NICU (ie discharged to rehab and/or other facilities).
- • NICU patients with a diagnosis of congenital heart disease requiring intervention during current admission (This is due to the fact that these patients already have specific discharge instructions/transition plan(s) in place).
- • Parents/guardians that are Non-English speaking will be excluded from the study due to the inability of the current study to provide all interventions in non-English languages.
About Northwell Health
Northwell Health is a leading integrated health system based in New York, dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to improving patient outcomes and enhancing medical knowledge, Northwell Health conducts a diverse range of clinical studies across various therapeutic areas. The organization harnesses its extensive network of hospitals, outpatient facilities, and research institutes to facilitate cutting-edge research, ensuring access to advanced treatments for patients while fostering collaboration among healthcare professionals, researchers, and industry partners. By prioritizing patient-centric approaches and leveraging state-of-the-art technology, Northwell Health aims to drive significant advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Queens, New York, United States
Patients applied
Trial Officials
Katherine Sullivan, MD
Principal Investigator
ksullivan14@northwell.edu
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported